An oncologist discusses the scary unknowns of COVID-19.
We know that COVID-19 is a major threat to people who are immunocompromised (including many patients with cancer), but there is still much about the virus that remains unknown, says Patrick I. Borgen, MD, chair of the Department of Surgery and director of the Breast Cancer Program at Maimonides Medical Center.
Transcription
One of the things that seems to be clear about COVID-19 is that it is really dangerous for immuno-suppressed patients. And we do a lot of immunosuppression in the cancer treatment world. So having a maximum amount of care and caution is the right thing for us to be doing right now.
I think that we're on the early-edge of understanding this. Is it possible that this is a seasonal virus that will settle in to another part of the flu vaccine? It is definitely possible. I don't believe this is SARS, I don't believe this is H1N1... But it might be stronger than the current flu that took 18,000 lives in the country this year. It could be a worse virus than that. So I think for me, what gives me pause, what makes me the most concerned, is that there is so much we don't know.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).